| Dr Ruchika Batwara, MD | |
|
1818 John F Kennedy Blvd, Jersey City, Jersey City, NJ 07305 | |
| (201) 333-8222 | |
| (201) 333-0095 |
| Full Name | Dr Ruchika Batwara |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 23 Years |
| Location | 1818 John F Kennedy Blvd, Jersey City, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164500146 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA09095300 (New Jersey) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | 25MA09095300 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Sinai St Luke's Roosevelt Hospital | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Icahn School Of Medicine At Mount Sinai | 2264691070 | 2339 |
News Archive
The U.S. Food and Drug Administration has announced its intention to take enforcement action against companies marketing unapproved injectable colchicine, a drug used to treat gout.
A global consumer survey has shown that of 14 European countries, the UK is where the most people report feeling body pain, defined as aches in the muscles, joints, tendons, and ligaments.
By analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their response to immune checkpoint inhibitor drugs.
A recent study by Feucht et al, published in the KSSTA Knee Journal, compared the Arthrosurface HemiCAP Wave implant, which is based on an "inlay" Arthroplasty design, versus an "onlay" design implant for isolated patellofemoral disease. While both implant groups showed similar improvements in function and pain scores, none of the patients in the "inlay" group showed progression of osteoarthritis (OA).
› Verified 4 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144581182 PECOS PAC ID: 2264691070 Enrollment ID: O20121128000010 |
News Archive
The U.S. Food and Drug Administration has announced its intention to take enforcement action against companies marketing unapproved injectable colchicine, a drug used to treat gout.
A global consumer survey has shown that of 14 European countries, the UK is where the most people report feeling body pain, defined as aches in the muscles, joints, tendons, and ligaments.
By analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their response to immune checkpoint inhibitor drugs.
A recent study by Feucht et al, published in the KSSTA Knee Journal, compared the Arthrosurface HemiCAP Wave implant, which is based on an "inlay" Arthroplasty design, versus an "onlay" design implant for isolated patellofemoral disease. While both implant groups showed similar improvements in function and pain scores, none of the patients in the "inlay" group showed progression of osteoarthritis (OA).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ruchika Batwara, MD 31 River Ct, Apt 1902, Jersey City, NJ 07310-2016 Ph: (414) 431-8516 | Dr Ruchika Batwara, MD 1818 John F Kennedy Blvd, Jersey City, Jersey City, NJ 07305 Ph: (201) 333-8222 |
News Archive
The U.S. Food and Drug Administration has announced its intention to take enforcement action against companies marketing unapproved injectable colchicine, a drug used to treat gout.
A global consumer survey has shown that of 14 European countries, the UK is where the most people report feeling body pain, defined as aches in the muscles, joints, tendons, and ligaments.
By analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their response to immune checkpoint inhibitor drugs.
A recent study by Feucht et al, published in the KSSTA Knee Journal, compared the Arthrosurface HemiCAP Wave implant, which is based on an "inlay" Arthroplasty design, versus an "onlay" design implant for isolated patellofemoral disease. While both implant groups showed similar improvements in function and pain scores, none of the patients in the "inlay" group showed progression of osteoarthritis (OA).
› Verified 4 days ago
Dr. Alita Logrono Dizon, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 377 Jersey Ave, Suite 460, Jersey City, NJ 07302 Phone: 201-332-4110 Fax: 201-332-4122 | |
Mrs. Sonia Castaneda Velasco, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 172 Newark Ave, Jersey City, NJ 07302 Phone: 201-332-4727 Fax: 201-332-4157 | |
Dr. Vladimir Znamensky, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 120 Franklin St, Jersey City, NJ 07307 Phone: 201-216-9791 Fax: 201-216-1362 | |
Saira Shah, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Medicine Dept,3rd Floor, Jersey City, NJ 07302 Phone: 201-915-2000 | |
Zorayda Olaya De Leon, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 311 Palisade Ave, Jersey City, NJ 07307 Phone: 201-963-5500 Fax: 201-963-5563 | |
Dr. Jared Saul Krok, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2431 | |
Merwin F Richard, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 550 Newark Ave, Ste 307, Jersey City, NJ 07306 Phone: 201-418-9111 Fax: 201-418-9118 |